United States Pharmaceuticals & Clinical Research Reservations open Page created Nov 16, 2026

List of Prescription Drug Wholesale Distributors Reported to the FDA

Companies that hold state wholesale distributor licences for prescription drugs and report them to the FDA under the Drug Supply Chain Security Act, grouped from individual facility licences into distributor companies for trade-relations, procurement and DSCSA compliance outreach.

Fields we plan to include

Company (legal name and DBA)
Facility address
Number of reported facilities
States with a reported wholesale licence
Licence numbers by state
Licence expiration dates
Latest FDA reporting year
Facility type (WDD or 3PL)
Company website
Main phone number

Data Preview

* Free sample rows, unverified and may contain errors. This list isn't for sale yet.
CompanyLocationOperating since
Bloodworth Wholesale DrugsSourceTifton, GA1978
Prescription Supply, Inc.SourceNorthwood, OH1955
Value Drug CompanySourceDuncansville, PA1934
Real Value RxSourceSan Antonio, TX2011
Atlantic BiologicalsSourceDistribution centers in North Carolina, Florida and Arizona1998

Estimated ~1,300 entries. If people reserve it, we'll try to compile it (we can't compile every list).

* No charge now. Purchase is optional.

How FDA wholesale distributor reporting works

Since 2015, the Drug Supply Chain Security Act (DSCSA) of 2013 has required every wholesale distributor of prescription drugs in the United States to report its state licences to the FDA each year, along with any significant disciplinary action. The FDA publishes the results in its Wholesale Distributor and Third-Party Logistics Providers Reporting database. Third-party logistics providers (3PLs) report under the same system but are flagged separately, because they store and ship product without taking ownership of it.

The database is organised by licence, not by company. A national distributor that ships into every state from a single warehouse appears once for each state licence, and a company with several distribution centers multiplies that again. In the FDA's WDD entries, roughly 31,000 licence rows resolve to about 1,960 distinct facilities and about 1,300 distinct legal entities. That gap is why trade-relations and compliance teams usually need the data rolled up before it is useful.

What a reported licence tells you

  • Legal name and DBA – the entity that holds the licence, which is often a subsidiary rather than the brand a pharmacy recognises.
  • Facility address – the physical warehouse or office the licence covers.
  • Licence state and number – the state that issued the licence; non-resident licences show where a distributor is allowed to ship, not where it sits.
  • Expiration date and reporting year – a licence that has lapsed or was not reported in the latest cycle is a flag worth checking before onboarding.

Who is in the population

The reporting population runs from the three national full-line wholesalers and their many subsidiaries, through regional full-line distributors that serve independent pharmacies, to secondary wholesalers focused on generics, specialty distributors for oncology and biologics, repackagers that also distribute, and manufacturers that hold wholesale licences to sell their own products. For a market-access team, the regional and secondary tiers are usually where the unknown trading partners are.

TierTypical customersWhy it matters
National full-lineChains, health systems, independentsMost volume, few legal entities but many licences
Regional full-lineIndependent pharmacies in a home regionPrimary supplier for many independents
Secondary / genericsIndependents topping up or buying genericsPrice-driven; licensed in many states from one site
SpecialtyClinics, oncology practices, specialty pharmaciesCold chain and limited-distribution products

Checking a trading partner under DSCSA

DSCSA allows a manufacturer, distributor or dispenser to transact only with authorized trading partners. For a wholesale distributor, that means a valid state licence and a current report to the FDA. Since the enhanced drug distribution security requirements took full effect, partners also exchange transaction information electronically at the package level, so qualifying a new distributor now involves confirming its licence status, its EPCIS connectivity and its verification process for suspect product. Accreditation from the NABP Drug Distributor Accreditation program is a common additional signal that buyers look for.

Practical notes for using the data

  1. Group by legal entity first, then by parent company; subsidiaries of the same group often report under different names.
  2. Count resident versus non-resident licences to see whether a distributor is truly regional or ships nationally from one site.
  3. Compare the reporting year across rows; a distributor that stopped reporting may have closed, merged or lost a licence.
  4. Keep 3PLs separate from distributors when the goal is a sales or trading-partner list, because a 3PL does not buy product.

Frequently Asked Questions

Q.What is the difference between a wholesale distributor and a 3PL under DSCSA?

A wholesale distributor takes ownership of prescription drugs and resells them. A third-party logistics provider stores, handles and ships product for a manufacturer or distributor without taking ownership. Both must be licensed and report to the FDA, but their DSCSA obligations differ, especially for transaction information.

Q.Does a distributor need a licence in every state it ships to?

Generally yes. Most states require a non-resident wholesale licence for any distributor shipping prescription drugs into the state, in addition to the resident licence where the facility sits. This is why one warehouse can generate dozens of licence records.

Q.What makes a distributor an authorized trading partner?

Under DSCSA, a wholesale distributor is an authorized trading partner if it holds a valid licence under state law (or federal licensing where applicable) and has reported its licences to the FDA as required. Manufacturers and dispensers may only buy from or sell to authorized trading partners.

Q.What is NABP Drug Distributor Accreditation?

It is a voluntary accreditation run by the National Association of Boards of Pharmacy that reviews a distributor's licensing, facilities, policies and security. Several states accept or require it, and many buyers treat it as a baseline check when onboarding a new wholesaler.

Q.Can I buy the list now?

Not yet. Sample rows are free. We try to compile lists that people reserve (we can't compile every list). If we do, we'll email everyone who reserved it a purchase link (buying is optional). If we don't, nothing happens and you're never charged.

Q.What does it cost?

Sample rows are free. A list is $49, paid only if we compile it and you decide to buy. There is no free trial or subscription.